The home healthcare market is predicted to capture a valuation of USD 3.2 billion in 2023 and is estimated to grow at USD 4.4 billion by 2033. The market is estimated to register a CAGR of 3.1% during the forecast period. Factors that drive the market size are given below:
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Prominent manufacturers are developing advanced healthcare devices to enhance the quality of treatment among patients. These manufacturers are making highly supportive devices that are easy to access, increasing patients' demand for home healthcare. Manufacturers' focus on providing environment-friendly medical devices propels market opportunities during the forecast period.
The adoption of telemedicine and digital monitoring equipment in emergencies are surging market opportunities. This equipment reduces a load of treatment due to its feature of easy to access and monitor patient's health. These are the few factors advancing the market growth with the manufacturer's innovations in the healthcare sector.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 3.1% |
| Market Valuation (2023) | USD 3.2 billion |
| Market Valuation (2033) | USD 4.4 billion |
According to Future Market Insights, the global home healthcare market is predicted at a healthy 3.1% CAGR during the forecast period. Historically, the market registered a CAGR of 2.6% between 2017 and 2022.
Introducing easy-to-use and portable medical devices have shifted patients' demand from hospitals to home healthcare in recent years. Increase in daily medical checkups and elder age people staying at home are fuelling the demand for home healthcare.
The adoption of Artificial Intelligence and the Internet of Things are developing smart devices which have taken the place of traditional healthcare systems.
Through these smart devices patients can check and manage their insulin levels with the use of insulin pens. The adoption of remote system devices for monitoring and reducing the overall cost are increasing the demand for home healthcare. Improvement in the quality of healthcare through relationship-based home care models for the disabled and geriatrics is fueling the market expansion.
The market is estimated to reach USD 4.4 billion during the forecast period. Historically, the market stood at USD 3.1 billion from 2017 to 2022.
| Segments | Product Type |
|---|---|
| Top Category | Infusion Systems |
| Historic CAGR | 2.6% |
| Forecast CAGR | 3.0% |
| Segments | Application |
|---|---|
| Top Category | Stoma Care |
| Historic CAGR | 2.6% |
| Forecast CAGR | 3.6% |
Based on product type, the infusion systems dominate the global market by occupying a CAGR of 3.0% during the forecast period. The adoption of infusion systems in-home healthcare services boosts market opportunities. As a result, infusion systems capture a huge revenue in the global market to supply liquid to patients’ bodies.
The rising adoption of infusion pumps is to deliver nutrients, pain relievers, antibiotics, and other medical doses. Clinical settings such as hospitals, nursing homes, and private residences drive market growth.
Additional features such as sirens, security measures, and other warnings are growing the sales of infusion systems. Historically, the infusion systems captured a CAGR of 2.6% between 2017 and 2022.
The stoma care application is expected to account for a CAGR of 3.6% during the forecast period. Adopting stoma care in home healthcare contributes to treat infections and rashes. The nurses and stoma specialists provide stoma care at home, traveling and ensuring convenience to the patients.
Intravenous (IV) medication is also expected to offer potential growth avenues to manufacturers of home healthcare systems. By 2033, the application area would represent a multi-billion-dollar opportunity. Historically, stoma care secured a CAGR of 2.6% between 2017 and 2022.
Top Countries Data Table Mentioned Below:
| Country | United States |
|---|---|
| CAGR (2017 to 2022) | 2.9% |
| CAGR (2023 to 2023) | 3.5% |
| Valuation (2023 to 2033) | USD 1.3 billion |
| Country | United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.2% |
| CAGR (2023 to 2023) | 3.9% |
| Valuation (2023 to 2033) | USD 357.5 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 2.4% |
| CAGR (2023 to 2023) | 2.9% |
| Valuation (2023 to 2033) | USD 316 million |
| Country | Japan |
|---|---|
| CAGR (2017 to 2022) | 2.9% |
| CAGR (2023 to 2023) | 3.4% |
| Valuation (2023 to 2033) | USD 246.6 million |
| Country | South Korea |
|---|---|
| CAGR (2017 to 2022) | 1.9% |
| CAGR (2023 to 2023) | 2.4% |
| Valuation (2023 to 2033) | USD 49.7 million |
The United States secures a CAGR of 3.5% with a valuation of USD 1.3 billion during the forecast period. Rising advanced healthcare infrastructure, the shift towards in-home healthcare services, and the growing generic population are expanding the United States home healthcare market. The increasing demand for nursing homes for private home health aides in the United States propels market share.
The growing aging population, wearable patient monitoring devices, and disposable income are accelerating the demand for home healthcare in the United States. Historically, the United States captured a CAGR of 2.9% between 2017 and 2022.
Innovation in Medical Home Healthcare Drives China Market?
China is expected to progress at significant growth by securing a CAGR of 2.9% with a valuation of USD 316 million during the forecast period. The growing significant urbanization, healthcare infrastructure, and advanced healthcare equipment drive China's home healthcare market. The rising chronic patients is increasing the adoption of home healthcare products and services.
Increasing medical supervision, individualized healthcare services, and home medical devices are the important factors driving the China market. Historically, China captured a CAGR of 2.4% between 2017 and 2022.
Japan is securing a significant CAGR of 3.4% with a valuation of USD 246.6 million during the forecast period. Furthermore, Japan is continuously growing the Asia Pacific market share through the initiative hospital at-home program, which reduced the cost of treatment by over 30%. In addition, the government is promoting home healthcare services to uplift the Japan home healthcare market growth.
There are various healthcare sectors that offer home care to patients, including baby and mother care, elderly care, and others. Additionally, the adoption of home healthcare also includes personalized and medical supervision healthcare services. Historically, Japan captured a CAGR of 2.9% between 2017 and 2022.
The United Kingdom secures a CAGR of 3.9% with valuation of USD 357.5 million during the forecast period. The rising disposable income, patients' preferences for treatment at home, and chronic diseases are increasing the demand for home healthcare in the country. In addition, rising government initiatives presence of healthcare providers and key manufacturers are the crucial factors bolstering the United Kingdom home healthcare market. Historically, the United Kingdom captured a CAGR of 3.2% between 2017 and 2022.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The prominent players are fragments of the global market by occupying a significant revenue. The market players are developing innovative devices and medical equipment to maintain daily check-ups at home. These devices are advanced and equipped with artificial intelligence, and new technology is flourishing the market expansion.
Healthcare providers prefer these devices to check patients' daily healthcare routine at the hospital, home, or any place. These players focus on developing easy-to-use equipment and adopting several marketing strategies to increase home healthcare sales. The rising popularity of online distribution channel is easy to reach relevant consumers and acquire huge market revenue.
Key Players operating in the Market are:
Recent Developments
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa, Türkiye |
| Key Segments Covered | Product Type, Application, Region |
| Key Companies Profiled | Coloplast A/S; B. Braun Melsungen AG; Baxter International Inc.; Hollister Incorporated; Becton Dickinson and Co; ConvaTec Group Plc; Medtronic plc.; Amedisys Home Health and Hospice Care; American Well; CVS Health; Humana Inc.; LHC Group Inc.; Kindred Healthcare |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The home healthcare market is predicted to record a 3.1% CAGR through 2033.
Hospital sector drives the home healthcare market.
The home healthcare market is expected to surpass USD 4.4 billion by 2033.
The home healthcare market is anticipated to be USD 3.2 billion in 2023.
The United States leads the home healthcare market during the forecast period.
| Estimated Size, 2025 | USD 4,330.8 million |
|---|---|
| Projected Size, 2035 | USD 9,702.0 million |
| Value-based CAGR (2025 to 2035) | 8.4% |
| Market Value (2023) | USD 38 Billion |
|---|---|
| Market Value (2033) | USD 197 Billion |
| Market CAGR (2023 to 2033) | 16.3% |
Explore Therapeutic Device Insights
View Reports
Home Healthcare Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
